PCCA Formula # 12132 Mesalamine 4 Gm/60 mL/Budesonide 2 mg/60 mL Poloxamer Enema
PCCA Formula # 12699 Mesalamine 4 Gm/60 mL/Budesonide 4 mg/60 mL Retention Enema (MucoLox™)
PCCA Formula # 1093 Sodium Acetate 60 mM/Sodium Propionate 30 mM/Sodium Butyrate 40 mM Enema
PCCA Formula # 12053 Sodium Butyrate 100 mM/Liter Enema (MucoLox™)
[Pinto A, et al. Short-chain fatty acids are effective in the short-term treatment of chronic radiation
proctitis: randomized, double-blind, controlled trial. Dis Colon Rectum. 1999 Jun;42(6):788-95;
discussion 795-6.]
PCCA Formula # 11373 Tacrolimus 4 mg/60 mL Rectal Enema (MucoLox™) [Lawrance IC, Baird A, Lightower D, Radford-Smith G, Andrews JM, Connor S. Efficacy of Rectal Tacrolimus for Induction Therapy in Patients With Resistant Ulcerative Proctitis. Clin Gastroenterol Hepatol. 2017 Aug;15(8):1248-1255.]
PCCA Formula # 11933 Tacrolimus 0.1% Rectal Gel (MucoLox™/VersaBase®) [Hart AL, Plamondon S, Kamm MA. Topical tacrolimus in the treatment of perianal Crohn’s disease: exploratory randomized controlled trial. Inflamm Bowel Dis. 2007 Mar;13(3):245-53.]
PCCA Formula # 12274 Curcumin 140 mg/20 mL Rectal Enema (MucoLox™) [Singla V, et al. Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis – a randomized, placebo-controlled, pilot study. J Crohns Colitis. 2014 Mar;8(3):208-14.]
PCCA Formula # 11928 Lidocaine HCl 1%/Beta Glucan 0.5%/Dexpanthenol 1%/Glutamine 2% Rectal Suspension Enema (MucoLox™